| Reversal of human cellular senescence: roles of the p53 and p16 pathways CM Beauséjour, A Krtolica, F Galimi, M Narita, SW Lowe, P Yaswen, ... The EMBO journal 22 (16), 4212-4222, 2003 | 1795 | 2003 |
| CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ S Herzig, S Hedrick, I Morantte, SH Koo, F Galimi, M Montminy Nature 426 (6963), 190-193, 2003 | 369 | 2003 |
| Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates G Solinas, W Naugler, F Galimi, MS Lee, M Karin Proceedings of the National Academy of Sciences 103 (44), 16454-16459, 2006 | 364 | 2006 |
| Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction L Naldini, E Vigna, A Bardelli, A Follenzi, F Galimi, PM Comoglio Journal of Biological Chemistry 270 (2), 603-611, 1995 | 318 | 1995 |
| Fate of endogenous stem/progenitor cells following spinal cord injury LL Horky, F Galimi, FH Gage, PJ Horner Journal of Comparative Neurology 498 (4), 525-538, 2006 | 314 | 2006 |
| Astrocytes contribute to gamma oscillations and recognition memory HS Lee, A Ghetti, A Pinto-Duarte, X Wang, G Dziewczapolski, F Galimi, ... Proceedings of the National Academy of Sciences 111 (32), E3343-E3352, 2014 | 295 | 2014 |
| Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro M Grano, F Galimi, G Zambonin, S Colucci, E Cottone, AZ Zallone, ... Proceedings of the National Academy of Sciences 93 (15), 7644-7648, 1996 | 284 | 1996 |
| A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer HL Kindler, DA Richards, LE Garbo, EB Garon, JJ Stephenson Jr, ... Annals of oncology 23 (11), 2834-2842, 2012 | 233 | 2012 |
| Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets V Cantaluppi, L Biancone, F Figliolini, S Beltramo, D Medica, ... Cell Transplantation 21 (6), 1305-1320, 2012 | 233 | 2012 |
| International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung … GV Scagliotti, I Vynnychenko, K Park, Y Ichinose, K Kubota, FH Blackhall, ... | 211 | 2012 |
| Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. C Boccaccio, G Gaudino, G Gambarotta, F Galimi, PM Comoglio Journal of Biological Chemistry 269 (17), 12846-12851, 1994 | 208 | 1994 |
| Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene S Giordano, Z Zhen, E Medico, G Gaudino, F Galimi, PM Comoglio Proceedings of the National Academy of Sciences 90 (2), 649-653, 1993 | 188 | 1993 |
| CRE recombinase-inducible RNA interference mediated by lentiviral vectors G Tiscornia, V Tergaonkar, F Galimi, IM Verma Proceedings of the National Academy of Sciences 101 (19), 7347-7351, 2004 | 185 | 2004 |
| Hepatocyte growth factor is a regulator of monocyte-macrophage function F Galimi, E Cottone, E Vigna, N Arena, C Boccaccio, S Giordano, ... The Journal of Immunology 166 (2), 1241-1247, 2001 | 172 | 2001 |
| Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. F Galimi, GP Bagnara, L Bonsi, E Cottone, A Follenzi, A Simeone, ... The Journal of Cell Biology 127 (6), 1743-1754, 1994 | 159 | 1994 |
| Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. F Galimi, GP Bagnara, L Bonsi, E Cottone, A Follenzi, A Simeone, ... The Journal of cell biology 127 (6), 1743-1754, 1994 | 159 | 1994 |
| Enhanced at puberty 1 (EAP1) is a new transcriptional regulator of the female neuroendocrine reproductive axis S Heger, C Mastronardi, GA Dissen, A Lomniczi, R Cabrera, CL Roth, ... The Journal of clinical investigation 117 (8), 2145-2154, 2007 | 134 | 2007 |
| Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors F Galimi, M Noll, Y Kanazawa, T Lax, C Chen, M Grompe, IM Verma Blood, The Journal of the American Society of Hematology 100 (8), 2732-2736, 2002 | 114 | 2002 |
| A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic … AL Cohn, J Tabernero, J Maurel, E Nowara, J Sastre, BYS Chuah, ... Annals of oncology 24 (7), 1777-1785, 2013 | 113 | 2013 |
| Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES C Pastore, GR Picchio, F Galimi, R Fish, O Hartley, RE Offord, DE Mosier Antimicrobial agents and chemotherapy 47 (2), 509-517, 2003 | 109 | 2003 |
